Optimization of Prostate Biopsy Referral Decisions

Jingyu Zhang (), Brian T. Denton (), Hari Balasubramanian (), Nilay D. Shah () and Brant A. Inman ()
Additional contact information
Jingyu Zhang: Department of Clinical Decision Support Solutions, Philips Research North America, Briarcliff Manor, New York 10510
Brian T. Denton: Edward P. Fitts Department of Industrial and Systems Engineering, North Carolina State University, Raleigh, North Carolina 27695
Hari Balasubramanian: Department of Mechanical and Industrial Engineering, University of Massachusetts, Amherst, Massachusetts 01003
Nilay D. Shah: Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905
Brant A. Inman: Department of Surgery, School of Medicine, Duke University, Durham, North Carolina 27710

Manufacturing & Service Operations Management, 2012, vol. 14, issue 4, 529-547

Abstract: Prostate cancer is the most common solid tumor in American men and is screened for using prostate-specific antigen (PSA) tests. We report on a nonstationary partially observable Markov decision process (POMDP) for prostate biopsy referral decisions. The core states are the patients' prostate cancer related health states, and PSA test results are the observations. Transition probabilities and rewards are inferred from the Mayo Clinic Radical Prostatectomy Registry and the medical literature. The objective of our model is to maximize expected quality-adjusted life years. We solve the POMDP model to obtain an age and belief (probability of having prostate cancer) dependent optimal biopsy referral policy. We also prove a number of structural properties including the existence of a control-limit type policy for the biopsy referral decision. Our empirical results demonstrate a nondecreasing belief threshold in age, and we provide sufficient conditions under which PSA screening should be discontinued for older patients. Finally, the benefits of screening under the optimal biopsy referral policy are estimated, and sensitivity analysis is used to prioritize the model parameters that would benefit from additional data collection.

Keywords: partially observable Markov decision process; PSA screening; biopsy; control-limit policy; stopping time problem (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (19)

Downloads: (external link)
http://dx.doi.org/10.1287/msom.1120.0388 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:inm:ormsom:v:14:y:2012:i:4:p:529-547

Access Statistics for this article

More articles in Manufacturing & Service Operations Management from INFORMS Contact information at EDIRC.
Bibliographic data for series maintained by Chris Asher ().